| High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma. | |
| | |
MedLine Citation:
|
PMID: 21328335 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Medullary breast cancer (MBC) is a basal-like breast carcinoma (BLBC) with a favourable outcome, whereas non-medullary BLBC has a poor prognosis. Tumour infiltrating lymphocytes (TILs) are present in both MBC and BLBC. We hypothesized that the immunosuppressive enzyme Indoleamine 2,3-dioxygenase (IDO) could modulate the TILs effects among these tumours and explain their different outcomes. The amount of TILs and IDO expression were analysed using immunohistochemistry (IHC) in 155 BC cases including MBC (n=17), atypical MBC (n=13) and non-MBC (n=125). Messenger RNA expression of the INDO gene, which encodes IDO, was measured in 262 cases from our institution. INDO mRNA expression and histoclinical data of 1,487 BC cases were collected from public databases. IDO immunostaining was present in both neoplastic and stromal cells in 100% of MBC and was associated with histological medullary features among non-MBC cases. There was a significant correlation between IDO positivity and TIL amounts. In our series including mostly grade-3 BC, IDO immunostaining was the most significant marker (p=0.02) associated with better survival in multivariate analysis. Among our 262 analysed BC cases, INDO mRNA showed significant overexpression in BLBC as compared to luminal A tumours, and in MBC as compared to basal-like non-MBC. In the pooled series of 1,749 BC cases, INDO mRNA was overexpressed in BLBC and was the most significant predictor of better survival in this subtype using multivariate analysis (p=0.0024). In conclusion, high IDO expression is associated with morphological medullary features and has an independent favourable prognostic value in BLBC. |
| | |
Authors:
|
Jocelyne Jacquemier; François Bertucci; Pascal Finetti; Benjamin Esterni; Emmanuelle Charafe-Jauffret; Marie-Laure Thibult; Gilles Houvenaeghel; Benoit Van den Eynde; Daniel Birnbaum; Daniel Olive; Luc Xerri |
Related Documents
:
|
9063535 - Salivary duct carcinoma metastasizing to the small bowel. 21479435 - Gene silencing of hprlr mrna by rna interference in human breast cancer cells. 21438905 - High-level cytoplasmic cyclin d1 expression in lymph node metastases from prostate canc... 21247495 - Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adh... 11466675 - Investigation of an interaction of alcohol intake and family history on breast cancer r... 15643195 - A decrease in 1h nuclear magnetic resonance spectroscopically determined citrate in hum... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-15 |
Journal Detail:
|
Title: International journal of cancer. Journal international du cancer Volume: - ISSN: 1097-0215 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0042124 Medline TA: Int J Cancer Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 UICC. |
Affiliation:
|
Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille; INSERM UMR891 ; IFR137, Marseille, France; Département de Bio-Pathologie, Institut Paoli-Calmettes, Marseille, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after...
Next Document: Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of ren...